Share Name Share Symbol Market Type Share ISIN Share Description
Sarossa LSE:SARS London Ordinary Share JE00BKWBZV64 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 1.52p 0 06:30:09
Bid Price Offer Price High Price Low Price Open Price
0.00p 0.00p - - -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 0.0 2.7 0.4 3.5 7.06

Sarossa (SARS) Latest News

Real-Time news about Sarossa (London Stock Exchange): 0 recent articles
More Sarossa News
Sarossa Takeover Rumours

Sarossa (SARS) Share Charts

1 Year Sarossa Chart

1 Year Sarossa Chart

1 Month Sarossa Chart

1 Month Sarossa Chart

Intraday Sarossa Chart

Intraday Sarossa Chart

Sarossa (SARS) Discussions and Chat

Sarossa Forums and Chat

Date Time Title Posts
31/8/201619:00Sarossa Ld39
14/2/201307:32Severe Acute Respiratory Syndrome Epidemic (SARS)114
07/4/200907:092 MILLION people could die in the UK within a few months20
07/8/200510:42SARS - Who will produce the Vaccine38
17/12/200311:38SARS-WHO WILL PROFIT FROM IT?26

Add a New Thread

Sarossa (SARS) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Sarossa trades in real-time

Sarossa (SARS) Top Chat Posts

johnsmith321: SARS price ticking up to 1.8p. With only 100M shares. I agree that NAV is down at the moment, but I think PHC and SLN will go back up to 100p and 300p soon. No yield for GVC for the first year as with the last acquisition. The acquisition should stop GVC being dependent on any single source for more 10% earnings. In addition the move up to the main market should be positive for the share price. They also promised to maintain same rate of dividend once acquisition is completed.
johnsmith321: Hi Callumross, Getting rid of the Abbvie pref shares made sense. As you say, they just cloud the investment picture. NAV up, investments up and profits up (if you exclude the one of Biotech legacy refund). Yet the share price has not moved. There must be a large share overhang. I do not care how they do it, but they should get the share price to 2p at least (as NAV per share is 3.35p). Perhaps they need to consolidate the shares 1:100 and get away from the penny share label. I like their follow on GVC investment (10% yield) should help to keep the NAV increasing year on year.
johnsmith321: Lets hope the next 48m shares does something to the share price :). They still have some cash. So they can continue buying back more shares. At some point the share price has to move.
johnsmith321: I was a bit disappointed that they bought so much. I was hoping they would do a little over a long time to make a constant demand for the stock. In addition, they would also make more news/publicity from buy back. I hope they also do a share consolidation after the buy back. Drag the company out of the penny stock label and into the respectable >£1 range. Perhaps then more funds may become interested. Would be nice to see 3.2p, the share price has not really moved despite the constant increase in NAV. This is a investment that is taking longer to mature, than I had hoped.
smellsnbells: The initial SARS exitement took place on the OMH thread. Osmetech sold a few SARS `sniffers` to China and the share price took off out of all proportion to reality. With the epidemic seemingly now contained it should see a price ajustment this week downward and a major world wide out break of death will not now materialise.
Sarossa share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20180317 10:56:08